Identification of AML and MDS Patients Who Could Potentially Benefit From Temozolomide Therapy: Proportion of Patients with Low Methyl Guanine Methyltransferase (MGMT) Expression Level. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Brandwein, Joseph
  • Kassis, Jeannine
  • Leber, Brian
  • Howson-Jan, Kang
  • Minden, Mark D
  • Greaves, Kim
  • Pouliot, Jean-Francois

publication date

  • November 19, 2010

published in